Please ensure Javascript is enabled for purposes of website accessibility

A Quick Glance at the Stocks in David Swensen's Yale Portfolio

By Motley Fool Staff – Updated Apr 6, 2017 at 9:28PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Learn from this fund's top holdings and new trades.

Every quarter, any fund managers overseeing more than $100 million must publicly disclose their quarter-end holdings in the Securities and Exchange Commission's Form 13-F. It lists all U.S.-traded securities the fund's manager held at the end of the quarter. Although the form doesn't disclose short positions or intraquarter trades, it can illuminate long stock bets.

Meet David Swensen
David Swensen has been managing the Yale University endowment fund since 1985. In a 2008 article, Fool contributor Tim Beyers called Swensen The Best Investor You've Never Heard Of. He also teaches at Yale. The total market value of Yale University's disclosed equity holdings as of March 31 -- the latest quarter for which data is available -- was $117.5 million across seven holdings. (Swensen is famous for maintaining positions across multiple asset classes.)

The endowment fund's seven U.S.-listed equity positions and associated share-count changes as of March 31 were:

  1. iShares MSCI Emerging Market Income ETF (NYSE: EEM) -- increased 91.8%
  2. SPDR S&P 500 ETF Trust (NYSE: SPY) -- no change
  3. iShares S&P 100 Index Fund (NYSE: OEF) -- no change
  4. iShares Trust MSCI EAFE Index Fund (NYSE: EFA) -- no change
  5. Dionex -- new holding
  6. Approach Resources (Nasdaq: AREX) -- new holding
  7. Wolverine World Wide (NYSE: WWW) -- no change

The Yale endowment also eliminated positions during the quarter in four stocks: Savvis (Nasdaq: SVVS), Genomic Health (Nasdaq: GHDX), Theravance (Nasdaq: THRX), and Goldman Sachs (NYSE: GS).

A look at what did well last quarter
Here's where Yale is winning and making new bets, at the moment:

  • Current winner: Wolverine World Wide did well, increasing 17% in the first quarter of the present year. Wolverine, however, is the smallest equity holding in the Yale endowment at just 0.7%.
  • New bets: The new additions, Dionex and Approach Resources, comprise 2.6% and 2.2% of the total portfolio, respectively.

So there you have it -- a quick glance at the equity portfolio of Yale University's endowment. Sound off with your thoughts in the comments section below.

Motley Fool newsletter services have recommended buying shares of Genomic Health. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Goldman Sachs Group, Inc. Stock Quote
The Goldman Sachs Group, Inc.
GS
$294.62 (-2.43%) $-7.35
SPDR S&P 500 ETF Trust Stock Quote
SPDR S&P 500 ETF Trust
SPY
$364.31 (-0.99%) $-3.64
Genomic Health, Inc. Stock Quote
Genomic Health, Inc.
GHDX
iShares, Inc. - iShares MSCI Emerging Markets ETF Stock Quote
iShares, Inc. - iShares MSCI Emerging Markets ETF
EEM
$35.54 (-1.22%) $0.44
Wolverine World Wide, Inc. Stock Quote
Wolverine World Wide, Inc.
WWW
$16.79 (-3.00%) $0.52
Approach Resources, Inc. Stock Quote
Approach Resources, Inc.
AREX
iShares Trust - iShares MSCI EAFE ETF Stock Quote
iShares Trust - iShares MSCI EAFE ETF
EFA
$55.92 (-1.48%) $0.84
iShares Trust - iShares S&P 100 ETF Stock Quote
iShares Trust - iShares S&P 100 ETF
OEF
$166.56 (-0.73%) $-1.22

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.